Comparably, studies of overall survival, relapse‐free survival or disease‐specific survival harmoniously illustrated that patients with high YWHAG‐expressing cancers had worse prognoses (HRs of 1.26‐58.02). The gene discussed is YWHAG; the disease is cancer.